The IBN SINA Pharmaceutical Industry PLC (DSE:IBNSINA)

Intra-Cellular Therapies Ratios and Metrics

Market cap in millions BDT. Fiscal year is July - June.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Market Capitalization	9,792	7,805	8,954	9,270	7,708	7,002
Market Cap Growth	9.31%	-12.84%	-3.40%	20.27%	10.08%	-15.15%
Enterprise Value	11,270	8,919	9,692	9,892	8,398	7,847
Last Close Price	313.40	244.69	274.85	278.97	228.05	203.91
PE Ratio	15.47	11.64	14.79	15.30	15.76	17.84
PS Ratio	0.83	0.69	0.98	1.09	1.05	1.13
PB Ratio	2.55	2.21	2.93	3.53	3.59	3.94
P/TBV Ratio	2.60	2.23	2.96	3.56	3.59	3.94
P/FCF Ratio	33.75	-	18.93	173.59	24.89	-
P/OCF Ratio	12.68	17.78	9.97	22.15	13.96	14.07
EV/Sales Ratio	0.95	0.78	1.06	1.17	1.14	1.27
EV/EBITDA Ratio	6.45	5.09	6.22	9.69	9.11	10.52
EV/EBIT Ratio	12.44	9.75	11.82	12.05	11.46	13.09
EV/FCF Ratio	38.85	-	20.49	185.25	27.12	-
Debt / Equity Ratio	0.48	0.53	0.32	0.41	0.40	0.54
Debt / EBITDA Ratio	1.06	1.06	0.62	1.02	0.91	1.25
Debt / FCF Ratio	6.36	-	2.09	20.02	2.80	-
Asset Turnover	1.76	1.98	1.96	2.08	2.03	1.98
Inventory Turnover	4.58	4.99	4.86	5.49	6.00	6.17
Quick Ratio	0.28	0.25	0.23	0.35	0.27	0.17
Current Ratio	1.18	1.13	1.26	1.46	1.26	0.83
Return on Equity (ROE)	17.58%	20.38%	21.33%	25.37%	24.91%	24.12%
Return on Assets (ROA)	8.42%	9.93%	11.00%	12.59%	12.58%	11.96%
Return on Capital (ROIC)	10.63%	12.08%	13.24%	15.30%	15.90%	15.24%
Return on Capital Employed (ROCE)	18.50%	21.80%	23.10%	25.80%	27.20%	28.00%
Earnings Yield	6.46%	8.59%	6.76%	6.54%	6.35%	5.61%
FCF Yield	2.96%	-2.24%	5.28%	0.58%	4.02%	-1.64%
Dividend Yield	2.01%	2.57%	2.18%	2.15%	2.06%	1.89%
Payout Ratio	32.22%	26.83%	29.49%	29.28%	26.89%	22.16%
Total Shareholder Return	2.01%	2.57%	2.18%	2.15%	2.06%	1.89%

Updated Jan 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.